生物转化
肠道菌群
脱水
代谢途径
化学
粪便
生物化学
新陈代谢
微生物学
生物
酶
作者
Cui Tang,Qiachi Fu,Xia Chen,Yang Hu,Helen J. Renaud,Chong Ma,Tai Rao,Yao Chen,Zhi‐Rong Tan,Curtis D. Klaassen,Shuyun Shi,Ying Guo
出处
期刊:Xenobiotica
[Taylor & Francis]
日期:2019-12-20
卷期号:50 (9): 1011-1022
被引量:11
标识
DOI:10.1080/00498254.2019.1707908
摘要
1. Bupleuri Radix (BR) is a herbal medicine traditionally used orally in oriental countries, which inevitably comes into contact with the intestinal microbiota. However, whether gut microbiota contribute to the biotransformation of BR, and/or the formation of pharmacologically active compounds remains unknown.2. In this study, the main saikosaponins (SAPs) of Bupleurum (including saikosaponin a, b1, b2, c, d, f, h) and BR extract (BRE) were individually incubated with human fecal suspensions (HFS), and metabolic time courses of SAPs and their metabolites by human gut bacteria were systematically characterized.3. Deglycosylation and dehydration were the main metabolic pathways identified for SAPs including newly investigated saikosaponin f (SSf) and saikosaponin h (SSh); dehydration had not been reported previously. A total of 19 dehydrated and deglycosylated metabolites of SAPs were detected and characterized, and 10 of them were newly identified. Moreover, SAPs of BRE were found to be deglycosylated to prosaikogenins. In addition, 13 metabolic pathways related to human gut microbiota were identified for phytochemicals of BRE except for SAPs. Gut microbiota may play a significant role in the biotransformation of BR in humans.
科研通智能强力驱动
Strongly Powered by AbleSci AI